Filing Details
- Accession Number:
- 0001593968-23-000096
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-09 15:17:09
- Reporting Period:
- 2023-01-05
- Accepted Time:
- 2023-01-09 15:17:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1673772 | Rapt Therapeutics Inc. | RAPT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1635616 | G. Dirk Brockstedt | C/O Rapt Therapeutics, Inc., 561 Eccles Avenue South San Francisco CA 94080 | Chief Scientific Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-01-05 | 742 | $21.97 | 19,070 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- These shares were sold solely to pay taxes due upon vesting of the Restricted Stock Units granted on January 30, 2020 for 8,000 shares.
Billionaire Hedge Funds
